Ignite Creation Date:
2025-12-24 @ 1:39 PM
Ignite Modification Date:
2025-12-27 @ 9:14 PM
Study NCT ID:
NCT06102395
Status:
RECRUITING
Last Update Posted:
2023-10-30
First Post:
2023-04-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Sponsor:
Beijing Tongren Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-12
First Submit QC Date:
None
Study First Post Date:
2023-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-26
Last Update Post Date:
2023-10-30
Last Update Post Date Type:
ACTUAL